Naked Short Web Site Announces UVE, SXRZF, GBBFF, CHNG, ORNID, OXIS Have Been Removed From Threshold Lists Today.
October 12, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net , announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists. Universal Insurance Holdings (AMEX: UVE), Uranium One (OTC: SXRZF), Gold Bullion Development (OTC: GBBFF), China Natural Gas (NASDAQ: CHNG), Oragenics (OTCBB: ORNID) and OXIS International (OTCBB: OXIS). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Universal Insurance Holdings, Inc. (AMEX: UVE), through its subsidiaries, operates as an insurance company. It performs various aspects of insurance underwriting, distribution, and claims processing. The companya�s primary product is homeownersa� insurance. As of December 31, 2009, it serviced approximately 531,000 policies with coverage for wind risks and 10,000 policies without wind risks. It markets and distributes its products and services through a network of independent agents. The company was formerly known as Universal Heights, Inc. and changed its name to Universal Insurance Holdings, Inc. in January 2001. Universal Insurance Holdings was founded in 1990 and is headquartered in Fort Lauderdale, Florida. There is no longer a failure to deliver in shares of UVE.
Uranium One Inc. (OTC: SXRZF), through its subsidiaries and joint ventures, engages in the acquisition, exploration, and development of uranium properties, as well as in the mining and production of uranium. The companya�s principal mineral properties include the Akdala Uranium mine, the South Inkai Uranium mine, the Karatau Uranium mine, and the Kharasan Uranium project located in Kazakhstan. It also has properties in the United States, South Australia, South Africa, and Canada. The company was formerly known as sxr Uranium One Inc. and changes its name to Uranium One Inc. in June 2007. Uranium One Inc. is headquartered in Vancouver, Canada. There is no longer a failure to deliver in shares of SXRZF.
Gold Bullion Development Corp. (OTC: GBBFF), a junior natural resource company, engages in acquiring, exploring, and evaluating mineral resource properties in Canada. The company explores for gold, silver, and copper deposits. It principal projects include the Granada Gold mine located in Rouyn-Noranda, Quebec; and the Castle Silver Mine property in Gowganda, Ontario. The company, formerly known as Consolidated Big Valley Resources Inc., was founded in 1985 and is headquartered in Surrey, Canada. There is no longer a failure to deliver in shares of GBBFF.
China Natural Gas, Inc. (NASDAQ: CHNG) engages in the distribution and sale of natural gas and gasoline to commercial, industrial, and residential customers in the Peoples' Republic of China. The company involves in the distribution and sale of compressed natural gas (CNG) and gasoline through its variable interest entity (VIE) owned CNG fueling stations to gasoline and hybrid powered vehicles. As of December 31, 2009, it operated 24 CNG fueling stations in Shaanxi province and 12 CNG fueling stations in Henan province. China Natural Gas also involves in the installation, distribution, and sale of piped natural gas through a high pressure pipeline network of approximately 120 kilometers in the Xian area comprising Lantian County, and the districts of Lintong and Baqiao in Shaanxi province. The company sold piped natural gas to approximately 108,423 residential customers. In addition, it operates automobile conversion sites that convert gasoline-fueled vehicles to hybrid (natural gas/gasoline) powered vehicles. The company was formerly known as Coventure International, Inc. and changed its name to China Natural Gas, Inc. in December 2005. China Natural Gas, Inc. was incorporated in 1999 and is headquartered in Xian, the Peoplea�s Republic of China. There is no longer a failure to deliver in shares of CHNG.
Oragenics, Inc. (OTCBB: ORNID), a biopharmaceutical company, engages in the discovery, development, and commercialization of various products and technologies associated with oral health, antibiotics, and other general health benefits in the United States. The company also has various products in discovery, preclinical, and clinical development concentrating in the therapeutic area of infectious diseases, in diagnostics, and in oral health. It operates in four divisions: Consumer Healthcare, Biomarker Discovery, Antibiotics, and Biologics. The Consumer Healthcare division develops oral probiotics based on the ProBiora3 technology that employs three natural strains of beneficial bacteria, which promote oral health; and weight loss products based on the LPT3-04, a weight loss agent (food/nutritional supplement). The Biomarker Discovery division offers Proteomic-based in-vivo induced antigen technology and Proteomic-based change mediated antigen technology platforms for the identification of genetic targets used in diagnostic tests, as well as in vaccines and therapeutics. The Antibiotics division is developing DPOLT or differentially protected orthogonal lantionine technology, a solid/liquid phase peptide synthesis platform technology that has various application for the manufacture of commercially important bioactive peptides, including lantibiotics; and MU 1140 an antibiotic with antimicrobial activity against drug resistant organisms, such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, and Streptococcus pneumoniae. The Biologics division develops SMaRT Replacement Therapy, a topical treatment under Phase I clinical trial against dental caries. The company, formerly known as Oragen, Inc., was founded in 1996 and is based in Alachua, Florida. There is no longer a failure to deliver in shares of ORNID.
OXIS International, Inc. (OTCBB: OXIS) engages in the research, development, and marketing of nutraceutical and cosmeceutical products in the field of oxidative stress reduction and inflammation. The company primarily focuses on developing a line of dietary supplements containing L-Ergothioneine (ERGO). ERGO is naturally occurring, water soluble, and amino acid antioxidant produced by microbes in the soil and found in various species of mushrooms and grapes, meats, and dairy products. It offers Ergo-Plex, a dietary supplement for the maintenance of joint health. The company also holds patents and patent applications for the protection of ERGO on mitochondria, the ERGO manufacturing process, and the neuroprotectant methods and compositions of ERGO. OXIS International, Inc. was founded in 1965 and is based in Beverly Hills, California. There is no longer a failure to deliver in shares of OXIS.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,800,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net